Methylome of skeletal muscle tissue in patients with hypertension and diabetes undergoing cardiopulmonary bypass.
Ghazal AghagoliAndrew Del ReNaohiro YanoZhiqi ZhangAhmad Aboul GheitRonald K PhillipsFrank W SellkeAlexey V FedulovPublished in: Epigenomics (2021)
Background: Epigenomic changes occurring during surgery have been neglected in research; diabetes and hypertension can affect the epigenome but little is known about the epigenetics of skeletal muscle (SKM). Methods: DNA methylation was profiled via Illumina MethylationEPIC arrays in SKM samples obtained at the beginning and end of heart surgery with cardiopulmonary bypass. Results: Methylation in patients with hypertension and diabetes was significantly different, more so for uncontrolled diabetes; hypertension alone produced minimal effect. The affected pathways involved IL-1, IL-12, IL-18, TNF-α, IFN-γ, VEGF, NF-κB and Wnt signaling, apoptosis and DNA damage response. Significant changes occurred during surgery and included loci in the Hippo-YAP/TAZ pathway. Conclusion: Cardiopulmonary bypass surgery affects the SKM methylome, and the combination of hypertension and diabetes induces changes in the SKM epigenome in contrast to hypertension alone.
Keyphrases
- blood pressure
- dna methylation
- type diabetes
- minimally invasive
- skeletal muscle
- cardiovascular disease
- coronary artery bypass
- glycemic control
- genome wide
- dna damage response
- insulin resistance
- magnetic resonance
- rheumatoid arthritis
- heart failure
- signaling pathway
- gene expression
- cell proliferation
- magnetic resonance imaging
- computed tomography
- immune response
- cell death
- endoplasmic reticulum stress
- adipose tissue
- arterial hypertension
- weight loss
- toll like receptor
- cell cycle arrest
- dna damage
- genome wide association study